Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Resistant Major Depression Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07512284
What this trial is testing

Mindfulness Engaged Neurostimulation for Depression (MEND II)

Who this might be right for
DepressionTreatment Resistant DepressionMajor Depressive Disorder+2 more
University of California, San Diego 120
Testing effectiveness (Phase 2)Ended earlyNCT05323019
What this trial is testing

Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Major Depressive Disorder
Zylorion Health 6
Not applicableStudy completedNCT02452892
What this trial is testing

Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

Who this might be right for
DepressionDepressive DisorderDepressive Disorder, Treatment-resistant+1 more
Tal Medical, Inc. 122
Post-approval studies (Phase 4)WithdrawnNCT05554627
What this trial is testing

VA Aripiprazole vs Esketamine for Treatment Resistant Depression

Who this might be right for
Depressive Disorder, Major
VA Office of Research and Development
Not applicableStudy completedNCT00531726
What this trial is testing

Berlin Deep Brain Stimulation Depression Study

Who this might be right for
Treatment Resistant Depression
Charite University, Berlin, Germany 11
Testing effectiveness (Phase 2)Study completedNCT00088699
What this trial is testing

Rapid Antidepressant Effects of Ketamine in Major Depression

Who this might be right for
DepressionMood DisordersMajor Depresssion
National Institute of Mental Health (NIMH) 67
Post-approval studies (Phase 4)Study completedNCT02356107
What this trial is testing

5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females

Who this might be right for
Major Depressive Disorder
Perry Renshaw 15
Early research (Phase 1)WithdrawnNCT03833063
What this trial is testing

Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression

Who this might be right for
Major Depressive DisorderMajor Depressive EpisodeTreatment Resistant Depression
Helse Stavanger HF
Not applicableStudy completedNCT05695365
What this trial is testing

Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms

Who this might be right for
Major Depressive Disorder
Iowa State University 9
Not applicableLooking for participantsNCT07115628
What this trial is testing

Accelerated TMS for Treatment-Resistant ECT

Who this might be right for
Major Depressive Disorder (MDD)
Universitair Ziekenhuis Brussel 200
Not applicableUnknownNCT02219867
What this trial is testing

Ketamine Infusions for Major Depression Disorder

Who this might be right for
Depressive Disorder, Major
Sheba Medical Center 10
Testing effectiveness (Phase 2)WithdrawnNCT05710887
What this trial is testing

N2O for Acute Suicidality and Depression in the ED

Who this might be right for
Suicidal IdeationMajor Depressive DisorderTreatment Resistant Depression
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT04608396
What this trial is testing

Mechanistic Evaluation of Response in TRD (MERIT)

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Axsome Therapeutics, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT01640080
What this trial is testing

The Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Janssen Research & Development, LLC 30
Testing effectiveness (Phase 2)Ended earlyNCT01913535
What this trial is testing

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
Massachusetts General Hospital 8
Testing effectiveness (Phase 2)Study completedNCT01778790
What this trial is testing

Deep Brain Stimulation of the Superolateral Branch of the Medial Forebrain Bundle (slMFB) for the Treatment of Refractory Major Depression

Who this might be right for
Major Depression
University Hospital, Bonn 16
Not applicableUnknownNCT05390593
What this trial is testing

Treatment for Major Depressive Disorder With Intermittent Theta-burst Stimulation

Who this might be right for
Depressive Disorder, Treatment-Resistant
Chang Gung Memorial Hospital 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07153406
What this trial is testing

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Who this might be right for
Depressive Disorder
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 220
Testing effectiveness (Phase 2)Ended earlyNCT04634669
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Axsome Therapeutics, Inc. 181
Not applicableLooking for participantsNCT06938841
What this trial is testing

Maintenance rTMS for Depression (Maitr-De)

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
University of California, San Diego 75
Next Page